No enforcement where the product is no longer marketed
Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes, section 6602, Sec. 6602.
Written by .
No enforcement where the product is no longer marketed
The document says “shall not”Who acts: Secretary of Health and Human ServicesHow: statuteSec. 6602 in the PDF
What the document says
“The Secretary shall not issue enforcement actions under section 303 for failures under this subsection in the case of a drug or biological product that is no longer marketed.''.”
Section 6602 adds a new paragraph (3) barring the Secretary from bringing enforcement actions under section 303 for these failures where the drug or biological product is no longer marketed.
What the document actually says
“The Secretary shall not issue enforcement actions under section 303 for failures under this subsection in the case of a drug or biological product that is no longer marketed.''.”
That sentence, in plain words
The health chief may not bring an action here if the drug is no longer sold.
What this is about
The point of the study is to guide use of a drug. If the drug is off the market, the study would guide nothing.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.
The quotation is the document's own words, exactly as printed, and we check the page
number against the Act itself before publishing. The paragraph underneath is our summary,
not the document's words. So is the plain English version, which is why it sits beside the
quotation rather than replacing it.
